Montelukast does not appear to increase the risk for neuropsychiatric adverse events in children and adolescents, according to a study published in JAMA Pediatrics. Montelukast is a leukotriene ...

Medically reviewed by Daniel More, MD Many people with asthma as children go into long periods of remission, with infrequent ...

Dr. Neha Reshamwala, owner of Frontier Allergy, Asthma & Immunology, with BioBehavioral Research of Austin (BBRA) stopped by ...

Conventional treatments for allergic rhinitis may also improve asthma outcomes in patients with both conditions. Read now!

In a world where respiratory issues are increasingly common, finding practical solutions can be daunting. Breathe Drops ...

The family of a Wisconsin man is suing after they say he died from an asthma attack when his medication price rose from $66 ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

BISMARCK, N.D. (KFYR) - Carrie Varner was diagnosed with the immunodeficiency disease Job’s Syndrome years ago. It can make ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

For the thousands of people who have asthma (a chronic lung disease that impacts your airways), the thought of vigorous exercise may be daunting. They ...

Centre, a national research platform led by Nanyang Technological University, Singapore’s (NTU Singapore) Lee Kong Chian School of Medicine (LKCMedicine), will lead a multi-institutional research ...